<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/37CD2BEF-8A0E-4320-92D5-329AD0B2010D"><gtr:id>37CD2BEF-8A0E-4320-92D5-329AD0B2010D</gtr:id><gtr:name>Mayo Foundation for Medical Education and Research (MFMER)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5A51966A-5E02-4F70-A0D3-68077A2C4C03"><gtr:id>5A51966A-5E02-4F70-A0D3-68077A2C4C03</gtr:id><gtr:name>Merck &amp; Co. Inc. (MSD)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/706E2AB4-3D79-432E-B0AE-899D9422B7EE"><gtr:id>706E2AB4-3D79-432E-B0AE-899D9422B7EE</gtr:id><gtr:name>Ecole Polytechnique F?d?rale de Lausanne (EPFL)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7D9B4D62-B1BB-4DEC-9664-795B9EC472D7"><gtr:id>7D9B4D62-B1BB-4DEC-9664-795B9EC472D7</gtr:id><gtr:name>School of Medicine Alabama at Birmingham</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/00FE3D00-46A6-4EDB-9672-1565C1E10DB8"><gtr:id>00FE3D00-46A6-4EDB-9672-1565C1E10DB8</gtr:id><gtr:name>Massachusetts Institute of Technology</gtr:name><gtr:address><gtr:line1>77 Massachusetts Avenue</gtr:line1><gtr:postCode>02139</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/BCAE40A9-5A38-4B94-A742-AEDAD7D4681F"><gtr:id>BCAE40A9-5A38-4B94-A742-AEDAD7D4681F</gtr:id><gtr:name>Leiden University Medical Centre</gtr:name><gtr:address><gtr:line1>PO Box 9600</gtr:line1><gtr:line4>Leiden</gtr:line4><gtr:line5>NL-2300 RC</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/EA2F440C-6AAD-4698-BDE9-27F559BDB96E"><gtr:id>EA2F440C-6AAD-4698-BDE9-27F559BDB96E</gtr:id><gtr:name>School of Medical Sciences</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/05F17A40-A0E2-4FF2-BC89-81C0CCE9A7D7"><gtr:id>05F17A40-A0E2-4FF2-BC89-81C0CCE9A7D7</gtr:id><gtr:name>Washington University at St Louis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/49FFE305-71E4-41B1-87AC-8E58220B1F28"><gtr:id>49FFE305-71E4-41B1-87AC-8E58220B1F28</gtr:id><gtr:name>Novartis Institutes for Biomedical Research (NIBR)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Genetics and Molecular Medicine</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/37CD2BEF-8A0E-4320-92D5-329AD0B2010D"><gtr:id>37CD2BEF-8A0E-4320-92D5-329AD0B2010D</gtr:id><gtr:name>Mayo Foundation for Medical Education and Research (MFMER)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5A51966A-5E02-4F70-A0D3-68077A2C4C03"><gtr:id>5A51966A-5E02-4F70-A0D3-68077A2C4C03</gtr:id><gtr:name>Merck &amp; Co. Inc. (MSD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/706E2AB4-3D79-432E-B0AE-899D9422B7EE"><gtr:id>706E2AB4-3D79-432E-B0AE-899D9422B7EE</gtr:id><gtr:name>Ecole Polytechnique F?d?rale de Lausanne (EPFL)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7D9B4D62-B1BB-4DEC-9664-795B9EC472D7"><gtr:id>7D9B4D62-B1BB-4DEC-9664-795B9EC472D7</gtr:id><gtr:name>School of Medicine Alabama at Birmingham</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/00FE3D00-46A6-4EDB-9672-1565C1E10DB8"><gtr:id>00FE3D00-46A6-4EDB-9672-1565C1E10DB8</gtr:id><gtr:name>Massachusetts Institute of Technology</gtr:name><gtr:address><gtr:line1>77 Massachusetts Avenue</gtr:line1><gtr:postCode>02139</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/BCAE40A9-5A38-4B94-A742-AEDAD7D4681F"><gtr:id>BCAE40A9-5A38-4B94-A742-AEDAD7D4681F</gtr:id><gtr:name>Leiden University Medical Centre</gtr:name><gtr:address><gtr:line1>PO Box 9600</gtr:line1><gtr:line4>Leiden</gtr:line4><gtr:line5>NL-2300 RC</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EA2F440C-6AAD-4698-BDE9-27F559BDB96E"><gtr:id>EA2F440C-6AAD-4698-BDE9-27F559BDB96E</gtr:id><gtr:name>School of Medical Sciences</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/05F17A40-A0E2-4FF2-BC89-81C0CCE9A7D7"><gtr:id>05F17A40-A0E2-4FF2-BC89-81C0CCE9A7D7</gtr:id><gtr:name>Washington University at St Louis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/49FFE305-71E4-41B1-87AC-8E58220B1F28"><gtr:id>49FFE305-71E4-41B1-87AC-8E58220B1F28</gtr:id><gtr:name>Novartis Institutes for Biomedical Research (NIBR)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3611393C-B14F-4035-B03B-9F07C2EAAD6F"><gtr:id>3611393C-B14F-4035-B03B-9F07C2EAAD6F</gtr:id><gtr:firstName>Gillian</gtr:firstName><gtr:surname>Bates</gtr:surname><gtr:orcidId>0000-0002-4041-6305</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0801314"><gtr:id>4037C11C-EA7D-4EF7-8F50-397C74BEFBB1</gtr:id><gtr:title>Investigation of Heat shock Factor 1 as a Therapeutic Target for Huntington s Disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801314</gtr:grantReference><gtr:abstractText>Increased life expectancy in the developed world has resulted in a greater incidence of age-related neurodegenerative disorders such as Alzheimer?s disease and Parkinson?s disease, which already impose a significant health, social and economic burden on families, communities and the country as a whole. Insight into the cause of these diseases has arisen through the study of rare genetic forms of Alzheimer?s and Parkinson?s disease as well as from inherited disorders like Huntington?s disease. The underlying mutations cause disease related proteins to misfold and adopt abnormal shapes allowing them to interact with themselves or other proteins in a detrimental manner. These aberrant interactions result in the malfunction and death of brain cells. Treatments that will slow or halt the progression of these ?protein-folding? diseases do not exist. 
All cells must ensure that as every protein is made, it is folded into the correct shape or conformation. Cells use ?chaperones? to fold proteins and if this is repeatedly unsuccessful, misfolded proteins are broken down or degraded. If this natural process to remove misfolded proteins becomes overwhelmed, as in the presence of a disease-related aggregation-prone protein, misfolded proteins accumulate and clump together as protein aggregates. The capacity of cells to maintain correctly folded proteins diminishes with age, resulting in an increasing susceptibility to protein-folding disease in the elderly. 
Strategies that might decrease the propensity of an aggregation-prone protein to misfold include increasing either the protein folding or protein degradation capacity of the cell. One possible approach is to harness the cells? natural defence against insults that cause proteins to misfold e.g. heat or toxic chemicals. This ?heat shock response? leads to the immediate increase in levels of many chaperones known as heat shock proteins and is switched on by heat shock factor 1 (HSF1). We have recently gained access to a drug that can cross the blood brain barrier and activate HSF1 in brain cells. We are also generating mouse models in which we can induce the presence of an activated form of HSF1 in brain. We shall use these complementary approaches understand the heat shock response in brain cells and to test whether activation of HSF1 can alleviate disease-related phenotypes in a mouse model of Huntington?s disease. This work will allow us to determine whether the activation of HSF1 should be pursued as a target for therapeutic development for Huntington?s disease and other neurodegenerative disorders.</gtr:abstractText><gtr:technicalSummary>Within the aging populations of the developed world the health, social and economic burden of neurodegenerative disease is already substantial and expected to increase. The occurrence of the most common neurodegenerative disorders: Alzheimer?s disease (AD), Parkinson?s disease (PD) and amyotrophic lateral sclerosis (ALS) is largely sporadic, however, rare familial cases of these diseases, together with inherited monogenic disorders such as Huntington?s disease (HD) have provided clues to their aetiology. In AD, PD, ALS and HD, mutations result in the propensity of disease-associated proteins to misfold, form a-sheet structures and become ?aggregation-prone? properties for which they have been named ?protein-folding? diseases. In all cases, disease-modifying therapies do not exist. 
All cells maintain protein-folding homeostasis through integrated protein-folding and clearance networks and pathways. Molecular chaperones direct the folding of newly synthesised and damaged proteins and those that cannot be successfully folded into their native conformation are degraded through the ubiquitin proteasome system (UPS) or cleared by lysosome-mediated autophagy. In the presence of an aggregation-prone protein, the mechanisms that maintain protein folding homeostasis become overwhelmed resulting in misfolding and aggregation. The capacity to maintain protein folding homeostasis diminishes with age, resulting in an increasing susceptibility to protein folding disease in the elderly. 
Strategies that might decrease the propensity of an aggregation-prone protein to misfold include increasing either the protein folding or protein degradation capacity of the cell. One possible approach is to induce the cellular stress response. Conditions of cellular stress including elevated temperature and oxidative damage activate the heat shock response which results in the immediate induction of heat shock proteins that encode molecular chaperones and other proteins important for the recovery from stress induced protein damage. Heat shock factor 1 (HSF1) is the master regulator of the heat shock response and can be activated pharmacologically by inhibition of Hsp90. We shall use complimentary approaches: exposure to elevated temperature, administration of a brain penetrant Hsp90 inhibitor and the generation of mice expressing an inducible form of activated HSF1 to define the neuronal heat shock response in vivo and to determine whether activation of HSF1 can alleviate disease-related phenotypes in a mouse model of HD. Thereby, we shall validate whether HSF1 activation is a rational therapeutic target for HD, and by extension, other protein-folding neurodegenerative disorders.</gtr:technicalSummary><gtr:fund><gtr:end>2014-02-28</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1523809</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London (KCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>FACS sorting</gtr:description><gtr:id>A334754A-59C8-4290-BE80-4AA3ACBEFCA4</gtr:id><gtr:impact>Carnemolla A, Lazell H, Moussaoui S, Bates GP (2015) In vivo profiling reveals a competent heat shock response in adult neurons: implications for neurodegenerative disorders. PLOS ONE 10, e0131985.</gtr:impact><gtr:partnerContribution>provided access to and technical support for use of a FACS facility</gtr:partnerContribution><gtr:piContribution>Use of facility for novel research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Medicine Alabama at Birmingham</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Biochemistry and Molecular Genetics</gtr:department><gtr:description>HD KI models</gtr:description><gtr:id>8D7889D5-E2C4-476E-B66F-310183E45F99</gtr:id><gtr:impact>Sathasivam K*, Neueder A*, Gipson TA, Landles C, Benjamin AC, Bondulich MK, Smith DL, Faull RLM, Roos RAC, Howland D, Detloff PJ, Housman DE, Bates GP (2013). Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington's disease. Proc. Natl. Acad. Sci. 110, 2366-2370.</gtr:impact><gtr:partnerContribution>provided mouse models</gtr:partnerContribution><gtr:piContribution>analysed mouse models in the publication below</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mayo Foundation for Medical Education and Research (MFMER)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>DBC1 KO mice</gtr:description><gtr:id>10EFB09B-B7B0-4C59-BEAA-577FA7759A5D</gtr:id><gtr:impact>Tulino R, Benjamin AC, Jolinon N, Smith DL, Chini EN, Carnemolla A, Bates GP (2016) SIRT1 activity is linked to brain region specific phosphorylation and is impaired in Huntington's disease. PLoS ONE 11, e145425.</gtr:impact><gtr:partnerContribution>The collaborators provided us with well-characterised in vivo materials that we did not have to generate or characterise ourselves</gtr:partnerContribution><gtr:piContribution>Used the materials in novel research</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts Institute of Technology (MIT)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Biology</gtr:department><gtr:description>RNAseq</gtr:description><gtr:id>89DB7011-271C-4CA0-81E0-BBDAA45D4B22</gtr:id><gtr:impact>Sathasivam K*, Neueder A*, Gipson TA, Landles C, Benjamin AC, Bondulich MK, Smith DL, Faull RLM, Roos RAC, Howland D, Detloff PJ, Housman DE, Bates GP (2013). Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington's disease. Proc. Natl. Acad. Sci. 110, 2366-2370.</gtr:impact><gtr:partnerContribution>Performed RNAseq on RNA supplied</gtr:partnerContribution><gtr:piContribution>Provided RNA from reagents generated in publication below</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London (KCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine KCL</gtr:department><gtr:description>chromatin immunoprecipitation</gtr:description><gtr:id>5C298CD1-E1FF-4537-B8CC-BAC78FADD3E6</gtr:id><gtr:impact>The data that arose from this collaboratrion were published in Labbadia J (2011) J. Clin. Invest. 121, 3306-3319.</gtr:impact><gtr:partnerContribution>providing us with access to equipment essential for experiments necessary for a publication</gtr:partnerContribution><gtr:piContribution>We were allowed access to equipment needed to prepare chromatin for immunoprecipitation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis Institutes for BioMedical Research (NIBR)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>HSP990</gtr:description><gtr:id>1C4C496C-C0C6-437F-BE9B-4CA8D9F2D6D5</gtr:id><gtr:impact>Labbadia J, Cunliffe H, Weiss A, Katsyuba E, Sathasivam K, Seredenina T, Woodman B, Moussaoui S, Frentzel S, Luthi-Carter R, Paganetti P, Bates GP (2011) Altered chromatin architecture underlies progressive impairment of the heat shock response in Huntington's disease mice. J. Clin. Invest. 121, 3306-3319.
Carnemolla A, Labbadia JP, Lazell H, Neueder A, Moussaoui S, Bates GP (2014) Contesting the dogma of an age-related heat shock response impairment; implications for cardiac-specific age-related disorders. Hum Mol Genet, 23, 3641-3656. 
Neueder A, Achilli F, Moussaoui S, Bates GP (2014) Novel isoforms of heat shock transcription factor 1, HSF1?a and HSF1??, regulate chaperone protein gene transcription. J Biol Chem, 289, 19894-19906. 
159. Carnemolla A, Lazell H, Moussaoui S, Bates GP (2015) In vivo profiling reveals a competent heat shock response in adult neurons: implications for neurodegenerative disorders. PLOS ONE 10, e0131985.</gtr:impact><gtr:partnerContribution>provided tool reagent</gtr:partnerContribution><gtr:piContribution>used the reagent to generate the data in the publication below</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Washington University at St Louis</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>SIRT1 Transgenic mice</gtr:description><gtr:id>5C744CB5-7D67-406C-B822-AB77BFC6974A</gtr:id><gtr:impact>Tulino R, Benjamin AC, Jolinon N, Smith DL, Chini EN, Carnemolla A, Bates GP (2016) SIRT1 activity is linked to brain region specific phosphorylation and is impaired in Huntington's disease. PLoS ONE 11, e145425.</gtr:impact><gtr:partnerContribution>Generation and characterisation of a transgenic mouse model</gtr:partnerContribution><gtr:piContribution>use of materials for novel research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Merck &amp; Co. Inc. (MSD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Gensat mice</gtr:description><gtr:id>816CE4F8-2417-4DE4-BD3C-CE637335F2A7</gtr:id><gtr:impact>Carnemolla A, Lazell H, Moussaoui S, Bates GP (2015) In vivo profiling reveals a competent heat shock response in adult neurons: implications for neurodegenerative disorders. PLOS ONE 10, e0131985.</gtr:impact><gtr:partnerContribution>The MMRRC provided access to four of the Gensat mouse lines. This saved us the cost of generating and characterising these lines ourselves</gtr:partnerContribution><gtr:piContribution>use of research materials for novel research</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Ophthalmology UCL</gtr:department><gtr:description>HSJ1a mice</gtr:description><gtr:id>5E9DE770-8A46-42DD-A203-B7AB2EAEF14D</gtr:id><gtr:impact>Labbadia J*, Novoselov SS*, Bett JS, Weiss A, Paganetti P, Bates GP#, Cheetham ME# (2012). Suppression of protein aggregation by chaperone modification of high molecular weight complexes. Brain 135, 1180-1196.</gtr:impact><gtr:partnerContribution>Supplied the HSJ1a transgenic mice and contributed to the analysis</gtr:partnerContribution><gtr:piContribution>performed a genetic cross between mice that are transgenic for the HSJ1a chaperone and a mouse model of HD.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Medical Sciences</gtr:collaboratingOrganisation><gtr:country>New Zealand</gtr:country><gtr:department>Anatomy and Radiology</gtr:department><gtr:description>HD brain</gtr:description><gtr:id>70E57B41-6946-4193-86F7-A0CB9444C18E</gtr:id><gtr:impact>Sathasivam K*, Neueder A*, Gipson TA, Landles C, Benjamin AC, Bondulich MK, Smith DL, Faull RLM, Roos RAC, Howland D, Detloff PJ, Housman DE, Bates GP (2013). Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington's disease. Proc. Natl. Acad. Sci. 110, 2366-2370.</gtr:impact><gtr:partnerContribution>provided post mortem samples</gtr:partnerContribution><gtr:piContribution>used post mortem brain material in publication below</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leiden University Medical Center (LUMC)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Department of Neurology</gtr:department><gtr:description>HD brain juvenile</gtr:description><gtr:id>53D5EB22-B9A1-4147-81DB-9571D077410D</gtr:id><gtr:impact>Sathasivam K*, Neueder A*, Gipson TA, Landles C, Benjamin AC, Bondulich MK, Smith DL, Faull RLM, Roos RAC, Howland D, Detloff PJ, Housman DE, Bates GP (2013). Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington's disease. Proc. Natl. Acad. Sci. 110, 2366-2370.</gtr:impact><gtr:partnerContribution>provided HD post mortem brain material</gtr:partnerContribution><gtr:piContribution>analysed brain material in the publication below</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ecole Polytechnique F?d?rale de Lausanne (EPFL)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>microarrays</gtr:description><gtr:id>1EB1CA66-BC36-41CD-8345-78AB07D8226E</gtr:id><gtr:impact>Labbadia J, Cunliffe H, Weiss A, Katsyuba E, Sathasivam K, Seredenina T, Woodman B, Moussaoui S, Frentzel S, Luthi-Carter R, Paganetti P, Bates GP (2011) Altered chromatin architecture underlies progressive impairment of the heat shock response in Huntington's disease mice. J. Clin. Invest. 121, 3306-3319.</gtr:impact><gtr:partnerContribution>performed expression microarrays on contractual basis</gtr:partnerContribution><gtr:piContribution>provided RNA for microarray analysis from reagents generated in this grant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>symposium at care home</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>20DC7814-1053-4184-B4A5-5D52DE09A1E7</gtr:id><gtr:impact>talk given to ~ 80 GPs, carers, physiotherapists etc involved in the care of HD patients.

Request to visit the research lab</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Careers afternoon for graduate students</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>17E29DDD-9959-4851-B78C-58ECF9AB046A</gtr:id><gtr:impact>Facilitated a careers afternoon for postgraduate students funded by the Neuromodel EU Marie Curie training netwrok

Good feedback from the students about the presentations and the opportunity to discuss career options</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit (Brompton Oratory)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DDC1DD76-8DF7-4EBF-AB17-22B9C73B0068</gtr:id><gtr:impact>talk to and discussion with 6th formers about the ethics and implications of genetic research

Very positive feedback, the school regretted not having made a video of the afternoon</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK HD netwrok</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>26D9EBC6-FBA1-44B4-8FFE-1F7AE3CF13F5</gtr:id><gtr:impact>Approximately 100 health professional involved in the care of Huntinton's disease (physiotherapists, psychologists, social workers etc.) and lay group members

Have been asked to address a psychiatric conference</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Headmasters annual conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>50992070-4722-42AE-BC2E-BD576E330C50</gtr:id><gtr:impact>Headmasters experienced going back to school for a day. Gave a lesson to approx. 30 headmasters

good feedback and request for transcript of presentation</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>KCL travel bursary</gtr:description><gtr:fundingOrg>King's College London (KCL)</gtr:fundingOrg><gtr:id>B98CBA9A-2BD1-4597-B32C-53B8E6C0A71E</gtr:id><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>222049</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>FP7 of the EU: networks for initial training</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>Community Research and Development Information Service (CORDIS)</gtr:fundingOrg><gtr:id>85DC08C5-ED59-4AAE-81A9-5EA14B172503</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2011-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>446910</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>response mode funding</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L003627/1</gtr:fundingRef><gtr:id>F225E54B-894E-4124-94D1-13D6BA207B52</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EU JPND research initiative</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>247E7682-B8A3-4C87-B6FE-B1B97B23A695</gtr:id><gtr:impact>The Joint Programming Initiative in Neurodegeneration (JPND) has been established by 23 European countries to address the growing societal challenge presented by age-related neurodegeneration. This initiative spans the biomedical, healthcare and social science agendas, and seeks to improve the scientific understanding of neurodegenerative disorders, provide new approaches for their prevention, diagnosis and treatment, and ensure effective provision of health and social care and support, so that individuals can receive optimum care at all stages of their illness.</gtr:impact><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>gene expression analysis of brains from HD mouse models and controls with or without induction of HSF1</gtr:description><gtr:id>B4C5FE97-BAF1-4DA8-AEF9-D1E37305AD44</gtr:id><gtr:impact>126. Labbadia J, Cunliffe H, Weiss A, Katsyuba E, Sathasivam K, Seredenina T, Woodman B, Moussaoui S, Frentzel S, Luthi-Carter R, Paganetti P, Bates GP (2011) Altered chromatin architecture underlies progressive impairment of the heat shock response in Huntington's disease mice. J. Clin. Invest. 121, 3306-3319.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>HSP990 microarrays</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>RNA seq from muscle of WT and HD mice treated with HS or HSP990</gtr:description><gtr:id>95941A55-D90B-4CC7-B5B5-ED37DD35890F</gtr:id><gtr:impact>None yet</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>heat shock muscle RNA seq</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>antibodies to novel HSF1 isoforms</gtr:description><gtr:id>6C0B3795-3A09-466C-B9A7-68B767CCB741</gtr:id><gtr:impact>new isoforms of HSF1 have been confirmed at the protein level</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>antibodies to HSF1 isoforms</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9A900FA0-70DA-42C3-8A96-57809C85BDE3"><gtr:id>9A900FA0-70DA-42C3-8A96-57809C85BDE3</gtr:id><gtr:title>Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1beaa99d5e16d4e7f1210cd930fe6d16"><gtr:id>1beaa99d5e16d4e7f1210cd930fe6d16</gtr:id><gtr:otherNames>Landles C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/46C8060C-F945-4D40-95C2-C58019BC6EA7"><gtr:id>46C8060C-F945-4D40-95C2-C58019BC6EA7</gtr:id><gtr:title>Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/55eae1db4cd48ede975f5e7c5177df67"><gtr:id>55eae1db4cd48ede975f5e7c5177df67</gtr:id><gtr:otherNames>Sathasivam K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8A1A41BE-864E-4AF4-8824-0B197F4F61DC"><gtr:id>8A1A41BE-864E-4AF4-8824-0B197F4F61DC</gtr:id><gtr:title>SIRT1 Activity Is Linked to Its Brain Region-Specific Phosphorylation and Is Impaired in Huntington's Disease Mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/006ed947bf9caa1eed0366c78b95fb23"><gtr:id>006ed947bf9caa1eed0366c78b95fb23</gtr:id><gtr:otherNames>Tulino R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B20B2852-BE4E-4ABF-931B-F5C297654465"><gtr:id>B20B2852-BE4E-4ABF-931B-F5C297654465</gtr:id><gtr:title>Contesting the dogma of an age-related heat shock response impairment: implications for cardiac-specific age-related disorders.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f7c805228e6181f87572a127cfe9d9e7"><gtr:id>f7c805228e6181f87572a127cfe9d9e7</gtr:id><gtr:otherNames>Carnemolla A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B5E1DC7A-DAC0-4A13-83B1-AC411273B253"><gtr:id>B5E1DC7A-DAC0-4A13-83B1-AC411273B253</gtr:id><gtr:title>Suppression of protein aggregation by chaperone modification of high molecular weight complexes.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/10cc748b43a0d6682acfc8aa07535c31"><gtr:id>10cc748b43a0d6682acfc8aa07535c31</gtr:id><gtr:otherNames>Labbadia J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F52297B7-3F03-480B-8920-0D12174F060F"><gtr:id>F52297B7-3F03-480B-8920-0D12174F060F</gtr:id><gtr:title>Aberrantly spliced HTT, a new player in Huntington's disease pathogenesis.</gtr:title><gtr:parentPublicationTitle>RNA biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f67eca64fa8f3e898d49b67d282b3d17"><gtr:id>f67eca64fa8f3e898d49b67d282b3d17</gtr:id><gtr:otherNames>Gipson TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1547-6286</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3EB4DB41-E40D-4811-89B1-331C93944988"><gtr:id>3EB4DB41-E40D-4811-89B1-331C93944988</gtr:id><gtr:title>In Vivo Profiling Reveals a Competent Heat Shock Response in Adult Neurons: Implications for Neurodegenerative Disorders.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f7c805228e6181f87572a127cfe9d9e7"><gtr:id>f7c805228e6181f87572a127cfe9d9e7</gtr:id><gtr:otherNames>Carnemolla A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3C92F0B2-DAF5-4836-BC6F-FF5C5804D867"><gtr:id>3C92F0B2-DAF5-4836-BC6F-FF5C5804D867</gtr:id><gtr:title>Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/10cc748b43a0d6682acfc8aa07535c31"><gtr:id>10cc748b43a0d6682acfc8aa07535c31</gtr:id><gtr:otherNames>Labbadia J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/29B3A8BF-5124-471C-979F-A1F85750056B"><gtr:id>29B3A8BF-5124-471C-979F-A1F85750056B</gtr:id><gtr:title>Novel isoforms of heat shock transcription factor 1, HSF1?a and HSF1??, regulate chaperone protein gene transcription.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/929fca3eb185486854503fcac8878d7c"><gtr:id>929fca3eb185486854503fcac8878d7c</gtr:id><gtr:otherNames>Neueder A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A2CF38B6-A66F-4D0E-88F6-85422A4103F1"><gtr:id>A2CF38B6-A66F-4D0E-88F6-85422A4103F1</gtr:id><gtr:title>Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/55eae1db4cd48ede975f5e7c5177df67"><gtr:id>55eae1db4cd48ede975f5e7c5177df67</gtr:id><gtr:otherNames>Sathasivam K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801314</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>